Houston's MD Anderson Cancer Center is one of the world's leading cancer treatment institutions, managing thousands of patients with Chronic Myeloid Leukaemia (CML) and Gastrointestinal Stromal Tumours (GIST) who require long-term Imatinib therapy. Imatib 400mg — the Indian generic equivalent of Gleevec — provides the same transformative treatment at a fraction of the branded cost.
Imatib contains Imatinib Mesylate 400mg, a first-generation BCR-ABL tyrosine kinase inhibitor (TKI) that revolutionised CML treatment after its introduction in 2001. By specifically blocking the BCR-ABL protein produced by the Philadelphia chromosome — the genetic abnormality driving CML — Imatinib prevents leukaemia cells from proliferating and induces apoptosis in existing cancer cells. It transformed CML from a disease with a 5-year survival rate of around 30% to one where most patients achieve complete molecular remission and near-normal life expectancy.
For GIST patients in Houston, Imatinib targets the mutated KIT and PDGFRA receptor tyrosine kinases that drive tumour growth, producing remarkable responses in what was previously a cancer with very limited treatment options. Houston oncologists at Memorial Hermann and Houston Methodist also use Imatinib for other BCR-ABL positive leukaemias and certain rare cancers.
Unnati Pharmax supplies Imatib 400mg to oncology pharmacies, cancer centres, and patients in Houston and across the USA. Visit medshopy.com or WhatsApp +91 82650 41513 for supply details.
Imatib contains Imatinib Mesylate 400mg, a first-generation BCR-ABL tyrosine kinase inhibitor (TKI) that revolutionised CML treatment after its introduction in 2001. By specifically blocking the BCR-ABL protein produced by the Philadelphia chromosome — the genetic abnormality driving CML — Imatinib prevents leukaemia cells from proliferating and induces apoptosis in existing cancer cells. It transformed CML from a disease with a 5-year survival rate of around 30% to one where most patients achieve complete molecular remission and near-normal life expectancy.
For GIST patients in Houston, Imatinib targets the mutated KIT and PDGFRA receptor tyrosine kinases that drive tumour growth, producing remarkable responses in what was previously a cancer with very limited treatment options. Houston oncologists at Memorial Hermann and Houston Methodist also use Imatinib for other BCR-ABL positive leukaemias and certain rare cancers.
Unnati Pharmax supplies Imatib 400mg to oncology pharmacies, cancer centres, and patients in Houston and across the USA. Visit medshopy.com or WhatsApp +91 82650 41513 for supply details.
